A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-positive Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction Adenocarcinoma

Clinical trial NCT07152405 · RECRUITING

Trial details

NCT number: NCT07152405
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Start date: 2025-09-24
Primary completion: 2027-06-01
Enrollment: 490

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.